Stay updated on Pembrolizumab for Meningioma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Meningioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Meningioma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The study record for pembrolizumab in recurrent or residual high-grade meningioma is now available, including eligibility criteria, study design, outcome measures, locations, and record documents.
    Difference
    55%
    Check dated 2026-11-09T12:51:43.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The site footer now displays revision v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-11-02T12:22:33.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    A sitewide NIH banner announces updates and FAQs about replacing the term “Artificial Intelligence” with “Super Intelligence” during a transition.
    Difference
    1%
    Check dated 2026-10-26T12:12:22.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2 while the study page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-19T12:47:41.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T14:45:40.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The study record page now displays a 403 Forbidden error instead of the usual content, indicating the page is temporarily inaccessible. This replaces the normal study details with an error screen, blocking viewing of the content.
    Difference
    20%
    Check dated 2026-09-21T19:58:42.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Meningioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Meningioma Clinical Trial page.